Thank you for subscribing!
Finfeed Archived Sep 03, 2018
The importance of biotech shouldn’t be underestimated, considering it can lead to tailor-made cures, eradication of diseases, better diagnostics and an overall healthier society.
Finfeed Archived Aug 30, 2018
Clinical-stage oncology company, Prescient Therapeutics (ASX:PTX), this morning updated the market on its trial of PTX-200 with cytarabine in relapsed or refractory acute myeloid leukaemia (AML).
Finfeed Archived Jul 26, 2018
Prescient Therapeutics Ltd (ASX:PTX) has received a Notice of Allowance for a new patent covering its lead clinical compound PTX-200 for the treatment of ovarian cancer in the United States.
Finfeed Archived Jul 19, 2018
When Rhythm Biosciences (ASX:RHY) listed on the ASX in December 2017 its slogan was ‘taking Australian innovation to the world’ - its delivered in spades.
Get expert stock analysis direct in your inbox
Finfeed Archived Jun 15, 2018
Medical diagnostics small cap Rhythm Biosciences Limited (ASX:RHY) has today announced that its new shareholder Merchant Group has increased its equity stake in the company from 5.02% to 7.01%.
Finfeed Archived Jun 12, 2018
Medical diagnostics innovator, Rhythm Biosciences (ASX:RHY), has welcomed leading biotech investor, Merchant Group, as a major new shareholder.
Finfeed Archived May 23, 2018
Bionomics Limited (ASX:BNO) has today announced that a Phase 2 clinical trial for BNC210 has commenced in elderly patients with agitation in a hospital setting.
Finfeed Archived May 22, 2018
Rhythm Biosciences Limited (ASX:RHY) has strengthened its management team by appointing two experienced health sector executives, including Glenn Gilbert as Chief Operating Officer.
Finfeed Archived May 21, 2018
BARD1 Life Sciences (ASX:BD1) has penned an assay development agreement with Thermo Fisher Scientific for custom research assay development of a multiplex autoantibody test using ProcartaPlex® technology.
Join Our Mailing List
